What is a Discussion Group? Problems Using Discussion Group? Changing E-mail Address?

PharmWeb


Pharmaceutical Sci-Tech Discussion Group


The Pharmaceutical Sci-Tech Discussion Group is designed to provide a vehicle for the free exchange of information, questions and answers about current issues, and access to relevant technical and regulatory documents. Its scope is international pharmaceutical manufacturing, quality control, process validation and regulatory affairs, emphasizing but not limited to sterile products technology. The discussion group is open to anybody with an interest in pharmaceutical science and technology.

This discussion group is sponsored and moderated by the Parenteral Drug Association (PDA), Bethesda, Maryland. PDA is an international non-profit professional association formed in 1946 to foster the art and science of pharmaceutical technology. Composed of over 7,000 members drawn from around the world, PDA annually sponsors many international scientific and regulatory meetings, a wide range of educational courses, routinely interacts with the FDA and other regulatory agencies, and publishes "The PDA Journal of Pharmaceutical Science and Technology" and the "PDA Letter".


* Go to ARCHIVE (contains messages exchanged on the Pharmaceutical Sci-Tech Discussion Group since September 27, 1996)


Sending a Message to the Pharmaceutical Sci-Tech Discussion Group

If you wish to send a message to the discussion group you must first join (see below). Once joined, you can contribute by sending an e-mail message to PharmTech@pharmweb1.man.ac.uk.

* Send a message to PharmTech@pharmweb1.man.ac.uk

Please remember to write your name, organisation and e-mail address at the bottom of your message
(if you have not joined the discussion group or use an incorrect e-mail address then your message will be rejected)


Joining/Leaving the Pharmaceutical Sci-Tech Discussion Group

If you would like to join or leave the Pharmaceutical Sci-Tech Discussion Group then please enter the following information:

E-mail address:
Your name (surname first):
e.g. Smith, John

Join the Discussion Group

Receive Individual Messages Receive Daily Digests

Leave the Discussion Group

Leave the Discussion Group


PharmWeb


PharmWeb - Copyright©1994. All rights reserved